Verastem, Inc. Interest Expense
Verastem, Inc. (VSTM) reported Interest Expense of $360.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-06
- Verastem, Inc. interest expense for the quarter ending 2026-06-30 was $360.00K, a 69.81% increase year-over-year.
- Verastem, Inc. interest expense for the quarter ending 2026-03-31 was $382.00K, a 98.96% increase year-over-year.
- Verastem, Inc. interest expense for the quarter ending 2025-12-31 was $415.00K, a 63.79% decline year-over-year.
- Verastem, Inc. interest expense for the quarter ending 2025-09-30 was $319.00K, a 72.21% decline year-over-year.
- Verastem, Inc. interest expense for fiscal 2025 was $1.14M, a 75.05% decline from fiscal 2024.
- Verastem, Inc. interest expense for fiscal 2024 was $4.56M, a 10.22% increase from fiscal 2023.
- Verastem, Inc. interest expense for fiscal 2023 was $4.14M, a 93.68% increase from fiscal 2022.
- Verastem, Inc. interest expense for fiscal 2022 was $2.14M, a 78.57% decline from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $360.00K 10-Q · filed 2026-08-06 | $743.00K 10-Q · filed 2026-08-06 | $1.16M derived: sum of 3 quarters · filed 2026-08-06 | $1.48M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $382.00K 10-Q · filed 2026-05-07 | $797.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.12M derived: sum of 3 quarters · filed 2026-05-07 | $1.33M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $415.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $734.00K derived: sum of 2 quarters · filed 2026-03-04 | $946.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.14M 10-K · filed 2026-03-04 | |
| 2025-09-30 | $319.00K 10-Q · filed 2025-11-04 | $531.00K derived: sum of 2 quarters · filed 2026-08-06 | $723.00K 10-Q · filed 2025-11-04 | $1.87M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $212.00K 10-Q · filed 2026-08-06 | $404.00K 10-Q · filed 2026-08-06 | $1.55M derived: sum of 3 quarters · filed 2026-08-06 | $2.70M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $192.00K 10-Q · filed 2026-05-07 | $1.34M derived: sum of 2 quarters · filed 2026-05-07 | $2.49M derived: sum of 3 quarters · filed 2026-05-07 | $3.62M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.29M derived: sum of 2 quarters · filed 2026-03-04 | $3.43M derived: sum of 3 quarters · filed 2026-03-04 | $4.56M 10-K · filed 2026-03-04 | $1.13M 10-Q · filed 2024-05-09 |
| 2024-09-30 | $1.15M 10-Q · filed 2025-11-04 | $2.29M derived: sum of 2 quarters · filed 2025-11-04 | $3.42M 10-Q · filed 2025-11-04 | $4.54M derived: sum of 4 quarters · filed 2026-03-04 | |
| 2024-06-30 | $1.14M 10-Q · filed 2025-08-07 | $2.27M 10-Q · filed 2025-08-07 | $3.39M derived: sum of 3 quarters · filed 2026-03-04 | $4.52M derived: sum of 4 quarters · filed 2026-03-04 | |
| 2024-03-31 | $1.13M 10-Q · filed 2025-05-13 | $2.25M derived: sum of 2 quarters · filed 2026-03-04 | $3.38M derived: sum of 3 quarters · filed 2026-03-04 | $4.50M derived: sum of 4 quarters · filed 2026-03-04 | |
| 2023-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.25M derived: sum of 2 quarters · filed 2026-03-04 | $3.37M derived: sum of 3 quarters · filed 2026-03-04 | $4.14M 10-K · filed 2026-03-04 | |
| 2023-09-30 | $1.13M 10-Q · filed 2024-11-06 | $2.25M derived: sum of 2 quarters · filed 2024-11-06 | $3.02M 10-Q · filed 2024-11-06 | $3.74M derived: sum of 4 quarters · filed 2025-03-20 | |
| 2023-06-30 | $1.12M 10-Q · filed 2024-08-08 | $1.89M 10-Q · filed 2024-08-08 | $2.61M derived: sum of 3 quarters · filed 2025-03-20 | $3.33M derived: sum of 4 quarters · filed 2025-03-20 | |
| 2023-03-31 | $769.00K 10-Q · filed 2024-05-09 | $1.49M derived: sum of 2 quarters · filed 2025-03-20 | $2.21M derived: sum of 3 quarters · filed 2025-03-20 | $2.85M derived: sum of 4 quarters · filed 2025-03-20 | |
| 2022-12-31 | $724.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $1.44M derived: sum of 2 quarters · filed 2025-03-20 | $2.08M derived: sum of 3 quarters · filed 2025-03-20 | $2.14M 10-K · filed 2025-03-20 | |
| 2022-09-30 | $717.00K 10-Q · filed 2023-11-08 | $1.36M derived: sum of 2 quarters · filed 2023-11-08 | $1.41M 10-Q · filed 2023-11-08 | $1.42M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-06-30 | $640.00K 10-Q · filed 2023-08-08 | $696.00K 10-Q · filed 2023-08-08 | $706.00K derived: sum of 3 quarters · filed 2024-03-14 | $8.69M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-03-31 | $56.00K 10-Q · filed 2023-05-09 | $66.00K derived: sum of 2 quarters · filed 2024-03-14 | $8.05M derived: sum of 3 quarters · filed 2024-03-14 | $9.05M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2021-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $7.99M derived: sum of 2 quarters · filed 2024-03-14 | $9.00M derived: sum of 3 quarters · filed 2024-03-14 | $9.97M 10-K · filed 2024-03-14 | |
| 2021-09-30 | $7.98M 10-Q · filed 2022-11-03 | $8.99M derived: sum of 2 quarters · filed 2022-11-03 | $9.96M 10-Q · filed 2022-11-03 | $11.32M derived: sum of 4 quarters · filed 2022-11-03 | |
| 2021-06-30 | $1.01M 10-Q · filed 2022-08-08 | $1.98M 10-Q · filed 2022-08-08 | $3.34M derived: sum of 3 quarters · filed 2022-08-08 | $5.23M derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-03-31 | $975.00K 10-Q · filed 2022-05-09 | $2.33M derived: sum of 2 quarters · filed 2022-05-09 | $4.23M derived: sum of 3 quarters · filed 2022-05-09 | $6.09M derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | $1.35M 10-K · filed 2021-03-18 | $3.25M derived: sum of 2 quarters · filed 2021-11-04 | $5.12M derived: sum of 3 quarters · filed 2021-11-04 | $15.79M 10-K · filed 2023-03-14 | |
| 2020-09-30 | $1.90M 10-Q · filed 2021-11-04 | $3.77M derived: sum of 2 quarters · filed 2021-11-04 | $14.44M 10-Q · filed 2021-11-04 | $19.89M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | $1.87M 10-Q · filed 2021-08-02 | $12.54M 10-Q · filed 2021-08-02 | $18.00M derived: sum of 3 quarters · filed 2021-08-02 | $23.04M derived: sum of 4 quarters · filed 2021-08-02 | |
| 2020-03-31 | $10.67M 10-Q · filed 2021-05-11 | $16.13M derived: sum of 2 quarters · filed 2021-05-11 | $21.17M derived: sum of 3 quarters · filed 2021-05-11 | $26.35M derived: sum of 4 quarters · filed 2021-05-11 | |
| 2019-12-31 | $5.45M 10-K · filed 2021-03-18 | $10.49M derived: sum of 2 quarters · filed 2021-03-18 | $15.68M derived: sum of 3 quarters · filed 2021-03-18 | $20.61M 10-K · filed 2022-03-28 | |
| 2019-09-30 | $5.04M 10-K · filed 2021-03-18 | $10.23M derived: sum of 2 quarters · filed 2021-03-18 | $15.16M 10-Q · filed 2020-11-09 | $19.11M derived: sum of 4 quarters · filed 2021-03-18 | |
| 2019-06-30 | $5.18M 10-K · filed 2021-03-18 | $10.12M 10-Q · filed 2020-08-10 | $14.07M derived: sum of 3 quarters · filed 2021-03-18 | $14.93M derived: sum of 4 quarters · filed 2021-03-18 | |
| 2019-03-31 | $4.93M 10-K · filed 2021-03-18 | $8.88M derived: sum of 2 quarters · filed 2021-03-18 | $9.74M derived: sum of 3 quarters · filed 2021-03-18 | $10.26M derived: sum of 4 quarters · filed 2021-03-18 | |
| 2018-12-31 | $3.95M 10-K · filed 2020-03-11 | $4.81M derived: sum of 2 quarters · filed 2020-03-11 | $5.33M derived: sum of 3 quarters · filed 2020-03-11 | $5.81M 10-K · filed 2021-03-18 | |
| 2018-09-30 | $862.00K 10-K · filed 2020-03-11 | $1.38M derived: sum of 2 quarters · filed 2020-03-11 | $1.86M 10-Q · filed 2019-10-30 | $2.19M derived: sum of 4 quarters · filed 2020-03-11 | |
| 2018-06-30 | $516.00K 10-K · filed 2020-03-11 | $996.00K 10-Q · filed 2019-08-01 | $1.32M derived: sum of 3 quarters · filed 2020-03-11 | $1.43M derived: sum of 4 quarters · filed 2020-03-11 | |
| 2018-03-31 | $480.00K 10-K · filed 2020-03-11 | $808.00K derived: sum of 2 quarters · filed 2020-03-11 | $918.00K derived: sum of 3 quarters · filed 2020-03-11 | $1.03M derived: sum of 4 quarters · filed 2020-03-11 | |
| 2017-12-31 | $328.00K 10-K · filed 2019-03-12 | $438.00K derived: sum of 2 quarters · filed 2019-03-12 | $547.00K derived: sum of 3 quarters · filed 2019-03-12 | $559.00K 10-K · filed 2020-03-11 | |
| 2017-09-30 | $110.00K 10-K · filed 2019-03-12 | $219.00K derived: sum of 2 quarters · filed 2019-03-12 | $231.00K 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $109.00K 10-K · filed 2019-03-12 | $121.00K 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | $12.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |